Literature DB >> 25921064

Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations.

Shruti Sharma1, Zhongbo Jin2, Elizabeth Rosenzweig1, Swapna Rao1, Kichul Ko1, Timothy B Niewold2.   

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease of uncertain etiology. Patients from different ancestral backgrounds demonstrate differences in clinical manifestations and autoantibody profiles. We examined genome-wide transcriptional patterns in major immune cell subsets across different ancestral backgrounds. Peripheral blood was collected from African-American (AA) and European-American (EA) SLE patients and controls. CD4 T-cells, CD8 T-cells, monocytes, and B cells were purified by flow sorting, and each cell subset from each subject was run on a genome-wide expression array. Cases were compared to controls of the same ancestral background. The overlap in differentially expressed gene (DEG) lists between different cell types from the same ancestral background was modest (<10%), and only 5-8% overlap in DEG lists was observed when comparing the same cell type between different ancestral backgrounds. IFN-stimulated gene (ISG) expression was not up-regulated synchronously in all cell types from a given patient, for example a given subject could have high ISG expression in T and B cells, but not in monocytes. AA subjects demonstrated more concordance in ISG expression between cell types from the same individual, and AA patients demonstrated significant down-regulation of metabolic gene expression which was not observed in EA patients. ISG expression was significantly decreased in B cells in patients taking immunosuppressants, while ISGs in other cell types did not differ with medication use. In conclusion, gene expression was strikingly different between immune cell subsets and between ancestral backgrounds in SLE patients. These findings emphasize the critical importance of studying multiple ancestral backgrounds and multiple cell types in gene expression studies. Ancestral backgrounds which are not studied will not benefit from personalized medicine strategies in SLE.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ancestral background; Gene expression; Interferon; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2015        PMID: 25921064      PMCID: PMC4457613          DOI: 10.1016/j.jaut.2015.04.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  43 in total

1.  Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus.

Authors:  Kichul Ko; Beverly S Franek; Miranda Marion; Kenneth M Kaufman; Carl D Langefeld; John B Harley; Timothy B Niewold
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

2.  Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.

Authors:  Corinna E Weckerle; Beverly S Franek; Jennifer A Kelly; Marissa Kumabe; Rachel A Mikolaitis; Stephanie L Green; Tammy O Utset; Meenakshi Jolly; Judith A James; John B Harley; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2011-04

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study.

Authors:  Elena Sánchez; Mary E Comeau; Barry I Freedman; Jennifer A Kelly; Kenneth M Kaufman; Carl D Langefeld; Elizabeth E Brown; Graciela S Alarcón; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle Petri; John D Reveille; Luis M Vilá; Joan T Merrill; Betty P Tsao; Diane L Kamen; Gary S Gilkeson; Judith A James; Timothy J Vyse; Patrick M Gaffney; Chaim O Jacob; Timothy B Niewold; Bruce C Richardson; John B Harley; Marta E Alarcón-Riquelme; Amr H Sawalha
Journal:  Arthritis Rheum       Date:  2011-11

5.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

Review 6.  How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets.

Authors:  Virginia Pascual; Florence Allantaz; Pinakeen Patel; A Karolina Palucka; Damien Chaussabel; Jacques Banchereau
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

7.  Increased 8-hydroxy-2'-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, anti-oxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leucocytes in patients with systemic lupus erythematosus.

Authors:  H-T Lee; C-S Lin; C-S Lee; C-Y Tsai; Y-H Wei
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

8.  High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.

Authors:  T B Niewold; J Hua; T J A Lehman; J B Harley; M K Crow
Journal:  Genes Immun       Date:  2007-06-21       Impact factor: 2.676

9.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

10.  Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients.

Authors:  Kichul Ko; Yelena Koldobskaya; Elizabeth Rosenzweig; Timothy B Niewold
Journal:  Front Immunol       Date:  2013-10-01       Impact factor: 7.561

View more
  25 in total

1.  A compendium of monocyte transcriptome datasets to foster biomedical knowledge discovery.

Authors:  Darawan Rinchai; Sabri Boughorbel; Scott Presnell; Charlie Quinn; Damien Chaussabel
Journal:  F1000Res       Date:  2016-03-07

Review 2.  New insights into the immunopathogenesis of systemic lupus erythematosus.

Authors:  George C Tsokos; Mindy S Lo; Patricia Costa Reis; Kathleen E Sullivan
Journal:  Nat Rev Rheumatol       Date:  2016-11-22       Impact factor: 20.543

3.  Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.

Authors:  Nailú Angélica Sinicato; Mariana Postal; Simone Appenzeller; Timothy B Niewold
Journal:  Pharmaceut Med       Date:  2017-01-25

Review 4.  Autoreactive B cells in SLE, villains or innocent bystanders?

Authors:  Jennie A Hamilton; Hui-Chen Hsu; John D Mountz
Journal:  Immunol Rev       Date:  2019-10-21       Impact factor: 12.988

Review 5.  Drugs in early clinical development for Systemic Lupus Erythematosus.

Authors:  Mariana Postal; Nailú Angélica Sinicato; Simone Appenzeller; Timothy B Niewold
Journal:  Expert Opin Investig Drugs       Date:  2016-04-07       Impact factor: 6.206

6.  B cells from African American lupus patients exhibit an activated phenotype.

Authors:  Laurence C Menard; Sium Habte; Waldemar Gonsiorek; Deborah Lee; Dana Banas; Deborah A Holloway; Nataly Manjarrez-Orduno; Mark Cunningham; Dawn Stetsko; Francesca Casano; Selena Kansal; Patricia M Davis; Julie Carman; Clarence K Zhang; Ferva Abidi; Richard Furie; Steven G Nadler; Suzanne J Suchard
Journal:  JCI Insight       Date:  2016-06-16

7.  Common genetic heterogeneity of human interleukin-37 leads to functional variance.

Authors:  Jingjing Yan; Yuling Zhang; Shimeng Cheng; Bin Kang; Jinbiao Peng; Xiaodan Zhang; Meichun Yuan; Wenqi Chu; Wen Zhang; Jiayin Shen; Shuye Zhang
Journal:  Cell Mol Immunol       Date:  2016-09-26       Impact factor: 11.530

Review 8.  Type I interferon in rheumatic diseases.

Authors:  Theresa L Wampler Muskardin; Timothy B Niewold
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 9.  Immunogenetics of systemic lupus erythematosus: A comprehensive review.

Authors:  Yogita Ghodke-Puranik; Timothy B Niewold
Journal:  J Autoimmun       Date:  2015-08-29       Impact factor: 7.094

Review 10.  Advances in lupus genetics.

Authors:  Timothy B Niewold
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.